FLIP(L) determines p53 induced life or death

How p53 differentially activates cell cycle arrest versus cell death remains poorly understood. Here, we demonstrate that upregulation of canonical pro-apoptotic p53 target genes in colon cancer cells imposes a critical dependence on the long splice form of the caspase-8 regulator FLIP (FLIP(L)), which we identify as a direct p53 transcriptional target. Inhibiting FLIP(L) expression with siRNA or Class-I HDAC inhibitors promotes apoptosis in response to p53 activation by the MDM2 inhibitor Nutlin-3A, which otherwise predominantly induces cell-cycle arrest. When FLIP(L) upregulation is inhibited, apoptosis is induced in response to p53 activation via a novel ligand-independent TRAIL-R2/caspase-8 complex, which, by activating BID, induces mitochondrial-mediated apoptosis. Notably, FLIP(L) depletion inhibits p53-induced expression of the cell cycle regulator p21 and enhances p53-mediated upregulation of PUMA, with the latter activating mitochondrial-mediated apoptosis in FLIP(L)-depleted, Nutlin-3A-treated cells lacking TRAIL-R2/caspase-8. Thus, we report two previously undescribed, novel FLIP(L)-dependent mechanisms that determine cell fate following p53 activation.

• Publication year

  2019

• Venue

  bioRxiv

• Publication date

  2019-11-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1101/858688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemical genomics reveals histone deacetylases are required for core regulatory transcription

  2019cited by this paper
• FLIP as a therapeutic target in cancer

  2018influential reference
• Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-κB Activation and Cell Survival

  2017cited by this paper
• Putting p53 in Context.

  2017cited by this paper
• Entinostat for the treatment of breast cancer

  2017cited by this paper
• Cell-to-Cell Variation in p53 Dynamics Leads to Fractional Killing.

  2016influential reference
• Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

  2016cited by this paper
• Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks

  2016cited by this paper
• HDAC inhibitors still need a home run, despite recent approval

  2015cited by this paper
• The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain.

  2015cited by this paper
• DED or alive: assembly and regulation of the death effector domain complexes

  2015influential reference
• Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress

  2014influential reference
• Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

  2014cited by this paper
• The transcription factor p53: Not a repressor, solely an activator

  2014cited by this paper
• Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis.

  2014cited by this paper
• Drugging the p53 pathway: understanding the route to clinical efficacy

  2014cited by this paper
• Drugging the p53 pathway: understanding the route to clinical efficacy

  2014cited by this paper
• Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway

  2014cited by this paper
• Small-Molecule Inhibitors of the MDM2–p53 Protein–Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment

  2014cited by this paper
• Differential affinity of FLIP and procaspase 8 for FADD’s DED binding surfaces regulates DISC assembly

  2014influential reference
• Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis

  2014cited by this paper
• MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

  2014cited by this paper
• Lysine-specific modifications of p53: a matter of life and death?

  2013cited by this paper
• BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response.

  2013cited by this paper
• Specific Acetylation of p53 by HDAC Inhibition Prevents DNA Damage-Induced Apoptosis in Neurons

  2013cited by this paper
• MDM2, MDMX and p53 in oncogenesis and cancer therapy

  2013cited by this paper
• The HDAC inhibitor depsipeptide transactivates the p53/p21 pathway by inducing DNA damage.

  2012cited by this paper
• Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis

  2012cited by this paper
• p63 maintains keratinocyte proliferative capacity through regulation of Skp2–p130 levels

  2011influential reference
• Chemical Phylogenetics of Histone Deacetylases

  2010cited by this paper
• Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells.

  2010cited by this paper
• Deacetylation of the DNA-binding Domain Regulates p53-mediated Apoptosis*

  2010cited by this paper
• Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair

  2010cited by this paper
• A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53

  2009cited by this paper
• 20 years studying p53 functions in genetically engineered mice

  2009cited by this paper
• Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment.

  2009cited by this paper
• Combined inhibition of FLIP and XIAP induces Bax-independent apoptosis in type II colorectal cancer cells

  2009cited by this paper
• Awakening guardian angels: drugging the p53 pathway

  2009influential reference
• Acetylation is indispensable for p53 activation.

  2008cited by this paper
• Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation

  2008cited by this paper
• Role for Histone Deacetylase 1 in Human Tumor Cell Proliferation

  2007cited by this paper
• Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa

  2007cited by this paper
• Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.

  2007cited by this paper
• Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.

  2006cited by this paper
• Acetylation of the p53 DNA-binding domain regulates apoptosis induction.

  2006cited by this paper
• Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate

  2006cited by this paper
• c-FLIP inhibits chemotherapy-induced colorectal cancer cell death

  2006cited by this paper
• Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis.

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression

  2004cited by this paper
• p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa

  2003cited by this paper
• Caspase‐10 is recruited to and activated at the native TRAIL and CD95 death‐inducing signalling complexes in a FADD‐dependent manner but can not functionally substitute caspase‐8

  2002cited by this paper
• MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation

  2002cited by this paper
• Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

  2002cited by this paper
• Caspase-10 is an initiator caspase in death receptor signaling

  2001cited by this paper
• PUMA, a novel proapoptotic gene, is induced by p53.

  2001influential reference
• Histone Deacetylases Specifically Down-regulate p53-dependent Gene Activation*

  2000cited by this paper
• Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site

  2000influential reference
• Surfing the p53 network

  2000cited by this paper
• p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

  1998influential reference
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

  1993cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992influential reference

• No citing papers are available for this paper.